1612758-88-9

1612758-88-9 structure

Name: Tabituximab barzuxetan
Chemical Name: Tabituximab barzuxetan
CAS Number: 1612758-88-9
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Stem Cell/Wnt Wnt
Create Date: 2023-02-03 12:15:02
Modify Date: 2024-04-08 16:16:07
Tabituximab barzuxetan (OTSA101-DTPA-90Y) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101), and labeled with Yttrium 90. Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research[1].

Name	Tabituximab barzuxetan

Description	Tabituximab barzuxetan (OTSA101-DTPA-90Y) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101), and labeled with Yttrium 90. Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Stem Cell/Wnt >> Wnt
References	[1]. Anne-Laure Giraudet , et al. A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018 Jun 8;18(1):646.

No Any Chemical & Physical Properties